1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,185 | 1,190 | 21:31 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Inside information: Bioretec adjusts and restates previously reported net sales FOR H1/2025 and does not expect accelerated sales in 2025 | 215 | PR Newswire | Bioretec Ltd Inside information 27 October 2025 at 9.14 p.m. EEST
TAMPERE, Finland, Oct. 27, 2025 /PRNewswire/ -- On 22 November 2024, Bioretec Ltd ("Bioretec" or the "Company")... ► Artikel lesen | |
| Mo | Inside information: Bioretec is revising its financial targets, deems that the current financial targets will not be met and withdraws its financial targets | 206 | PR Newswire | Bioretec Ltd Inside information 26 October 2025 at 10.00 a.m. EEST
TAMPERE, Finland, Oct. 27, 2025 /PRNewswire/ -- On 12 September 2025, Bioretec Ltd ("Bioretec" or the "Company")... ► Artikel lesen | |
| 01.10. | Bioretec's RemeOs Screw LAG Solid Receives CMS Transitional Pass-Through Payment in the US | 182 | PR Newswire | TAMPERE, Finland, Oct. 1, 2025 /PRNewswire/ -- Bioretec Ltd, a pioneer in absorbable orthopedic implants, announced today that the Centers for Medicare & Medicaid Services (CMS) has granted... ► Artikel lesen | |
| BIORETEC Aktie jetzt für 0€ handeln | |||||
| 01.10. | Bioretec's RemeOs Trauma Screw Approved for Transitional Pass-Through Payment in the U.S. | 2 | Cision News | ||
| 16.09. | Composition of Bioretec's Shareholders' Nomination Board | 3 | Cision News | ||
| 15.09. | Bioretec Oy: Inside information: Anne-Mari Matikainen appointed as Interim Chief Financial Officer of Bioretec; CFO Johanna Salko to depart before year-end | 115 | GlobeNewswire (Europe) | Bioretec Ltd Inside information 15 September 2025 at 5.30 p.m. EEST
Bioretec Ltd., a pioneer in absorbable orthopedic implants appoints Anne-Mari Matikainen as Interim Chief Financial Officer, effective... ► Artikel lesen | |
| 15.09. | New shares of Bioretec Ltd subscribed with option rights have been registered with the trade register | 1 | Cision News | ||
| 15.09. | Bioretec Oy: Shares Subscribed With Option Rights | 144 | GlobeNewswire | NOTICE, SEPTEMBER 15, 2025 SHARES (Record Id 315934) A total of 5,000 shares will be traded as old shares as of September 16, 2025 on First North Growth Market Finland.
Identifiers of Bioretec Oy's... ► Artikel lesen | |
| 12.09. | Bioretec Oy: Inside information: Bioretec updates the commercialization status of RemeOs DrillPin | 246 | GlobeNewswire (Europe) | Bioretec Ltd Inside information 12 September 2025 at 11:00 a.m. EEST
Bioretec Ltd., a pioneer in absorbable orthopedic implants, announces an update to the commercialization status of the RemeOs DrillPin.... ► Artikel lesen | |
| 04.09. | Bioretec adds Harvard orthopedic surgeon to scientific board | 2 | Investing.com | ||
| 04.09. | Bioretec Appoints Dr. Christopher W. DiGiovanni to Scientific Advisory Board | 201 | PR Newswire | Bioretec Ltd Press Release 4 September 2025 at 3 p.m. EET
TAMPERE, Finland, Sept. 4, 2025 /PRNewswire/ -- Bioretec Ltd., a pioneer in bioresorbable orthopedic implants, today announced... ► Artikel lesen | |
| 02.09. | Bioretec Appoints Jordy Winters as Vice President of OUS Sales to Accelerate International Growth | 610 | PR Newswire | TAMPERE, Finland, Sept. 2, 2025 /PRNewswire/ -- Bioretec Ltd, a pioneer in absorbable orthopedic implants, announced today the appointment of Jordy Winters
as Vice President of Sales... ► Artikel lesen | |
| 28.08. | Bioretec Ltd: Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings (W&M GmbH) | 3 | Cision News | ||
| 27.08. | Bioretec selects its next CEO | 2 | MassDevice | ||
| 27.08. | Bioretec Appoints Sarah van Hellenberg Hubar-Fisher as Chief Executive Officer | 295 | PR Newswire | TAMPERE, Finland, Aug. 27, 2025 /PRNewswire/ -- Bioretec Ltd., a pioneer in absorbable orthopedic implants, announced today the appointment of Sarah van Hellenberg Hubar-Fisher as Chief Executive... ► Artikel lesen | |
| 14.08. | Bioretec Ltd's Half-year report 2025: Strong support for future growth from a successful rights issue | 368 | PR Newswire | TAMPERE, Finland, Aug. 14, 2025 /PRNewswire/ -- Bioretec Ltd Company announcement 14 August 2025 at 8.00 am EEST
This company announcement is a summary of Bioretec Ltd's half-year report... ► Artikel lesen | |
| 11.07. | René Eve appointed as Director of Operations of Bioretec Ltd. | 2 | Cision News | ||
| 27.06. | Bioretec Ltd adjusts the terms and conditions of its stock option programs due to the completed rights issue | 411 | PR Newswire | TAMPERE, Finland, June 27, 2025 /PRNewswire/ -- Bioretec Ltd Company announcement 27 June 2025 at 8.00 am EEST
As previously announced, Bioretec Ltd ("Bioretec" or the "Company") has... ► Artikel lesen | |
| 26.06. | New shares of Bioretec Ltd registered with the trade register | 5 | Cision News | ||
| 24.06. | Final results of Bioretec Ltd's successful rights issue | 646 | PR Newswire | TAMPERE, Finland, June 24, 2025 /PRNewswire/ -- Bioretec Ltd Company announcement 24 June 2025 at 18:30 EEST
NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY... ► Artikel lesen |
1 2 3 Weiter >>
41 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 16,910 | -2,82 % | Eckert & Ziegler-Aktie im Mittelpunkt - Experten erwarten bald starke Reaktion! | ||
| DRAEGERWERK | 75,60 | -0,92 % | Ascom Holding AG: Ascom, Dräger, and B. Braun Launch Silent ICU Solution, a Milestone in Patient-Centric Critical Care | Baar, Switzerland, 28 October 2025
Ascom, in partnership with Dräger and B. Braun, announces the launch of the Silent ICU solution, introduced at the ESICM LIVES 2025 Congress in Munich. This is... ► Artikel lesen | |
| INTUITIVE SURGICAL | 466,85 | -1,46 % | Intuitive Surgical-Aktie +16%: Kommt das große Comeback? | Nachdem die Intuitive Surgical-Aktie bereits am Montag und Dienstag in Summe um fast +8% zugelegt hat, schießt sie am Mittwochmorgen um +16% in die Höhe. Was steckt hinter dem großen Kurssprung des... ► Artikel lesen | |
| INSULET | 280,40 | +0,25 % | What to Expect From Insulet's Next Quarterly Earnings Report | ||
| CYTOSORBENTS | 0,743 | +3,19 % | CytoSorbents Corporation: CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR | FDA appeal decision found no issues with DrugSorb-ATR device safety but upheld the De Novo denial, and proposes a potential path forward for market authorization... ► Artikel lesen | |
| GENEDX | 137,30 | +5,08 % | GeneDx verfehlt Gewinnprognose deutlich - Aktie gibt trotz Umsatzplus nach | ||
| REVENIO GROUP | 24,700 | -1,00 % | Revenio Group Corporation: Revenio is planning to develop its organization to become increasingly customer-centric and is initiating organizational change negotiations | Revenio Group Corporation | Press Release | September 17, 2025 at 11:20:00 EEST
In recent years, Revenio Group has made a significant journey from being a diagnostic device provider to becoming a global... ► Artikel lesen | |
| OPTOMED | 3,970 | -0,63 % | Optomed Oyj: Half-year Report, January - June 2025 | Optomed Plc Stock Exchange Release 7 August 2025 at 9.00, Helsinki
Optomed Plc: Half-year Report, January - June 2025
April - June 2025
Revenue increased by 9.7 percent to EUR 3.8 (3.5) million.
Currency-adjusted... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 48,860 | -1,25 % | JEFFERIES stuft Siemens Healthineers auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für Siemens Healthineers mit einem Kursziel von 60 Euro auf "Buy" belassen. Die Übernahme von Hologic zeuge vom "Appetit von... ► Artikel lesen | |
| FRESENIUS | 49,720 | +0,67 % | Fresenius: Etwas mehr Optimismus für 2025 | Am 5. November gibt es von Fresenius die Zahlen zum dritten Quartal. Die Analysten der Deutschen Bank rechnen mit einem soliden Wachstum. Sie erwarten ein organisches Umsatzplus von 4 Prozent. Bei der... ► Artikel lesen | |
| GERRESHEIMER | 28,380 | -3,47 % | freenet, Gerresheimer, GFT, Heidelberg Materials, Mutares, Südzucker - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 46,490 | -0,43 % | Branicks, CTS Eventim, FMC, Norma Group, Puma, Zalando - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| UNITEDHEALTH | 317,10 | +0,51 % | Earnings Preview - Teil 1: UnitedHealth, Alphabet und Microsoft: Die heißeste Woche des Jahres steht an! | © Foto: Richard Drew/AP/dpaDiese in den kommenden Tagen (KW44) anstehenden US-Quartalszahlen müssen Anlegerinnen und Anleger kennen: Herausforderungen, Erwartungen und die aktuell eingepreisten Kursreaktionen... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 44,500 | -1,59 % | DEUTSCHE BANK RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Hold' | FRANKFURT (dpa-AFX Analyser) - Deutsche Bank Research hat das Kursziel für Carl Zeiss Meditec von 45 auf 46 Euro angehoben, aber die Einstufung auf "Hold" belassen. Analyst Falko Friedrichs rechnet... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 34,060 | +0,77 % | A Look at BrightSpring Health's Upcoming Earnings Report |
Das Unternehmen BIORETEC OY kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 1,180 Euro und damit +1,29 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BIORETEC OY finden Sie auf Wallstreet Online.